"10.1371_journal.pone.0060150","plos one","2013-03-28T00:00:00Z","Innocent Safeukui; Pierre A Buffet; Sylvie Perrot; Alain Sauvanet; Beatrice Aussilhou; Safi Dokmak; Anne Couvelard; Dominique Cazals Hatem; Narla Mohandas; Peter H David; Odile Mercereau-Puijalon; Geneviève Milon","Institut Pasteur, Immunologie Moléculaire des Parasites, Département de Parasitologie Mycologie, Paris, France; CNRS, URA2581, Paris, France; Center for Rare and Neglected Diseases, University of Notre Dame, Notre Dame, Indiana, United States of America; INSERM - UPMC (Paris 6 University) UMRs945, Paris, France; AP-HP, Department of Parasitology, Pitié Salpétrière Hospital, Paris, France; Department of Surgery, Beaujon Hospital, AP-HP, Clichy, France; Department of Pathology, Beaujon Hospital, AP-HP, Clichy, France; New York Blood Centre, New York, New York, United States of America; Institut Pasteur, Immunophysiologie et Parasitisme, Département de Parasitologie Mycologie, Paris, France","Conceived and designed the experiments: IS PAB NM PHD OMP GM. Performed the experiments: IS PAB SP. Analyzed the data: IS PAB SP NM PHD OMP GM. Contributed reagents/materials/analysis tools: IS PAB AS BA SD AC DCH. Wrote the paper: IS PAB SP AS BA SD AC DCH NM PHD OMP GM.","The authors declare Sanofi-Aventis as a competing interest. However, this does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2013","03","Innocent Safeukui","IS",12,TRUE,6,3,7,12,TRUE,TRUE,FALSE,0,NA,FALSE
